OSLER
LIVE

Serial Number

79254769

Owner

Osler Diagnostics Limited

Attorney

Eric Lamb

Filing Date

Jan 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

OSLER Trademark

Serial Number: 79254769 • Registration: 6039152

OSLER is a trademark filed by Osler Diagnostics Limited on January 29, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 25 (Clothing). The application is currently registered and active.

Owner Contact Info

Osler Diagnostics Limited (12 trademarks)

King Charles House,

Entity Type: 99

Trademark Details

Filing Date

January 29, 2019

Registration Date

April 28, 2020

Published for Opposition

February 11, 2020

Goods & Services

Research in the field of education; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Scientific apparatus and instruments, namely, hand-held devices for withdrawing and testing blood for clinical, research, and scientific purposes and parts and fittings therefor; material testing apparatus and instruments, namely, electronic apparatus for identifying and testing pathogens and biomarkers in blood for clinical, research, and scientific purposes; monitoring, measuring, signaling and control apparatus and instruments, namely, apparatus and instruments for testing blood against a panel of biomarkers for clinical, research, and scientific purposes; audiovisual receivers; computer apparatus and instruments, namely, computer hardware and computer peripheral apparatus; recorded computer software for analyzing data obtained from blood samples; downloadable computer software for analyzing data obtained from blood samples; recorded application software for analyzing data obtained from blood samples; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; electrical and electronic components for computers; parts and fittings for all the aforementioned goods

Pharmaceuticals for treating viruses, infections, infectious diseases, and skin disorders; medical preparations for treating viruses, infections, infectious diseases, and skin disorders; chemical preparations and reagents for medical purposes for treating viruses, infections, infectious diseases, and skin disorders; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for testing blood and body fluids

Clothing namely shirts, pants, coats, dresses and jackets; footwear; headgear namely hats, caps as clothing, and headwear

Assays and reagents for scientific or medical research purposes

Intellectual property licensing services; licensing of technology; licensing of manufacturing technology and/or manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property and/or industrial property rights; licensing of patents and intellectual property in the field of confidential information, technical information and/or know-how; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Medical services; medical testing for diagnostic purposes; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Medical apparatus and instruments for use in obtaining blood samples; medical apparatus and instruments for testing blood for diagnostic use; medical apparatus and instruments for identifying pathogens and biomarkers from blood samples; diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; parts and fittings for all the aforementioned goods

Product research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; new product design services; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of diagnostic tests for the measurement of clinical biomarkers; software research, design and development services; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 28, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 8, 2023 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 2, 2023 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 28, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 28, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 28, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 28, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 28, 2023 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 29, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 7, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 22, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 22, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 26, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 26, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 26, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 26, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 20, 2019 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Dec 20, 2019 PBSR
ASSIGNED TO LIE
Dec 11, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 25, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 25, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 25, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 25, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2019 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 26, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 5, 2019 ADCH
REFUSAL PROCESSED BY IB
Jun 1, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 11, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 11, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 18, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 17, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 10, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 30, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 21, 2019 REPR